Abstract

BackgroundAmong rheumatoid arthritis (RA) patients, the influence of antinuclear antibodies (ANA) in clinical response to anti-TNFα treatment has been suggested. However, recent studies showed conflicting results.ObjectivesTo determine the impact of...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Antinuclear Antibody Positivity in Chronic Hepatitis C Patients: Effect on Histopathology and Impact on Early Response to Combined Antiviral Therapy
Yehia Younes ... Rania Amer
Afro-Egyptian Journal of Infectious and Endemic Diseases | VOL. 5
Yehia Younes, et. al.Yehia Younes ... Rania Amer
25 Jun 2015
THU0225 The Induction of Antinuclear Antibodies in Spondyloarthritis Patients Under Anti-TNF Alpha: A New Outcome Predictor?
M Bernardes ... R Fonseca
Annals of the Rheumatic Diseases | VOL. 74
M Bernardes, et. al.M Bernardes ... R Fonseca
01 Jun 2015
FRI0501 Antinuclear Antibody-Positive Patients – are they a Separate Entity?
M Glerup ... T Herlin
Annals of the Rheumatic Diseases | VOL. 74
M Glerup, et. al.M Glerup ... T Herlin
01 Jun 2015
Characterization of anti-nuclear antibodies in patients with oral submucous fibrosis and its clinicopathologic implications - An immunofluorescence study.
Lipsa Bhuyan ... Bijoykumar Das
Journal of oral and maxillofacial pathology : JOMFP | VOL. 25
Lipsa Bhuyan, et. al.Lipsa Bhuyan ... Bijoykumar Das
01 Jan 2020
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers